-
Flash Session I (C)
Rafaella CoelhoDone
-
Enterprise Plenary Session III
Sofia Venceslau (Ph.D.)Done
-
Lunch Break
Done
-
Flash Session III (A)
Inês SerrenhoDone
-
Oral Session I C
Diana GomesDone
-
Coffee and Pastel de Nata @Nata Lisboa Covilhã and City Center Walk
Done
-
Flash Session II (B)
Ana ValenteDone
-
Enterprise Plenary Session I
Josué Carvalho (Ph.D.)Done
-
Hot Topics II: New biomolecules: Challenges in the development and clinical translation
Carlos Neto, PharmD: Medical Scientific Liaison at Angelini Pharma Portugal and Pedro Madureira, Co-founder and CSO at IMMUNETHEPDone
-
Oral Session II B
Margarida CarvalhoDone
Enterprise Plenary Session II
14/02/2023, 17:20
-
14/02/2023, 18:20
(UTC)
(1 hour)
Carlos Neto (PharmD)
Medical Science Liaison - Neuroscience
at Angelini Pharma
carlos.neto@angelinipharma.com
PharmD, 7 + years of experience in the Pharmaceutical Industry, namely in Medical Affairs & Clinical Research, at Janssen, AstraZeneca, and Angelini Pharma. Therapeutic areas: Neuroscience, Cardiometabolism, Oncology, and Immuno-Oncology. Currently works at the Medical Affairs department of Angelini (national launch of new product in Neurology). Experienced researcher with two international experiences (University of Oxford, UK, and University of Bonn, Germany) and past filiation with iMed.UL.